In this study, mental disorders were determined using data from the Danish Psychiatric Central Research Register and general medical conditions from the Danish National Patient Register.
A deep dive into clinical efficacy and safety of using psychedelic-assisted therapy for depression, anxiety, PTSD, substance use disorder, and other mental health disorders
A roundup on legislative and organizational initiatives to stem the rising rates of opioid overdose deaths.
Outpatients with schizophrenia who were seeking treatment for cannabis use disorder were recruited between 2017 and 2020 at the Center for Addiction and Mental Health in Canada.
Barriers to medications for opioid use disorder in teens and young adults include Black race, Hispanic and Latino ethnicity, living in the South, and involvement in the criminal justice system.
“We’ve learned in the past 20 years or so how harmful trauma exposure is across physical, mental, and behavioral health.”—Elinam D. Dellor, PhD, MSW
A roundup on legislative and organizational initiatives to stem the rising rates of drug overdose deaths.
Expert describes the diagnostic criteria for cannabis use disorder and other cannabis-related disorders.
Debra R. Newman, PA-C, MSPAS, MPH, practices addiction medicine in the criminal justice system and is an educator on opioid use disorder management.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
